Business description: iShares Trust - iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Sales by Activity: iShares Trust - iShares Nasdaq Biotechnology ETF

Fiscal Period: March 2020 (USD) 2021 (USD) 2022 (USD) 2023 (USD) 2025 (USD)

Unclassified Services

50.53M 65.99M 64.73M 58.15M 48.45M

Geographical breakdown of sales: iShares Trust - iShares Nasdaq Biotechnology ETF

Fiscal Period: March 2020 (USD) 2021 (USD) 2022 (USD) 2023 (USD) 2025 (USD)

United States

50.53M 65.99M 64.73M 58.15M 48.45M

Company details: iShares Trust - iShares Nasdaq Biotechnology ETF

iShares Biotechnology ETF

45 Fremont Street

94105, San Francisco

+415 670 2000

address iShares Trust - iShares Nasdaq Biotechnology ETF(IBB)

Investment Trusts

Change 5d. change 1-year change 3-years change Capi.($)
Average
Weighted average by Cap.
  1. Stock Market
  2. Equities
  3. IBB Stock
  4. Company iShares Trust - iShares Nasdaq Biotechnology ETF